Salma Muhyedeen

Salma Muhyedeen

Auto-generated profile, based on publicly available information

Salma Muhyedeen

Department of Pediatrics, NYC Health + Hospitals/Queens , Queens, NY, 11432

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 January 2026 in Journal of Sickle Cell Disease
Verified
Journal Article
Open access
CDCandice Deler
Candice Deler
SMSalma Muhyedeen
Salma Muhyedeen
TDToni Denicola
Toni Denicola
CACandace Alphonso
Candace Alphonso
UPUrvi Patel
Urvi Patel
KRKenneth Rivlin
Kenneth Rivlin
Objectives: Hydroxyurea (HU) is an evidence-based, disease-modifying therapy that reduces complications for individuals with sickle cell disease (SCD). Despite its benefits, HU uptake remains suboptimal, particularly in historically marginalized communities facing barriers such as healthcare mistrust, misinformation, and structural inequities. In 2020, NYC Health + Hospitals (H + H) launched a citywide initiative, funded by the US Office of Minority Health, to improve HU use by partnering with community-based organizations (CBOs) and community health workers (CHWs) to address these barriers. Methods: The initiative was evaluated through an independent, mixed-methods study conducted by the New York State Department of Health. This system-wide intervention reached over 300 providers, with 99 actively participating in the incentive program, and impacted approximately 400 pediatric patients annually, with outcomes assessed in a matched cohort of 730 Medicaid-enrolled patients. Our CBO’s intervention involved culturally grounded health education, peer support, and practical assistance with non-clinical needs. Evaluation methods included qualitative interviews with clinicians, CHWs, and program leaders, supplemented by quantitative analyses of healthcare utilization and pharmacy data from pre- (2019) and post-intervention (2022-2023) periods. Results: The CBO–hospital partnership was essential to the initiative’s success. The CBO provided trusted community infrastructure, within which CHWs delivered frontline education, navigation, and social support, addressed social determinants of health and strengthened trust between families and clinical teams. Statistically significant improvements were observed: HU fills increased from 57% to 79%, adherence improved from 33% to 40%, and patients seen by participating providers were significantly less likely to have emergency department visits after adjustment. Qualitative data confirmed that the CBO-anchored CHW model was a critical driver of these outcomes. Conclusion: Integrating trusted community organizations into clinical care models can overcome entrenched barriers, improve HU adherence, and advance health equity in SCD care.